Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$289,696
+$3,994 QoQ
Shares Held
800
-1.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#2,575
of 3,140 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tripletail Wealth Management, LLC holds $2,827,313 across 10 Drug Manufacturers - General names. AMGN ranks #4 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
706 | $846,797 | |
| 2 | ABBV |
AbbVie Inc.
|
2,579 | $648,979 | |
| 3 | GSK |
GSK plc
|
10,497 | $550,252 | |
| 4 | AMGN |
Amgen Inc
This page
|
800 | $289,696 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,026 | $260,341 | |
| 6 | NVS |
Novartis AG
|
790 | $123,808 | |
| 7 | JNJ |
Johnson & Johnson
|
260 | $66,032 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
376 | $21,665 |
All Filings in AMGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $289,696 | 800 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $285,702 | 812 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $271,012 | 828 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $239,870 | 850 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $237,328 | 850 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||